Endostar (rh‐endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer: A systematic review and meta‐analysis

Endostar (rh‐endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer: A systematic review and meta‐analysis

Abstract Background We aimed to clarify the benefits of the addition of rh‐endostatin into concurrent chemoradiotherapy (CCRT) versus CCRT alone for locally advanced non‐small cell lung cancer (NSCLC) by a meta‐analysis. Methods PubMed, Embase, Cochrane Central Register of Controlled Trials, Wanfang...

Full description

Bibliographic Details
Main Authors: Meng Yuan, Yirui Zhai, Yu Men, Jianyang Wang, Lei Deng, Wenqing Wang, Yongxing Bao, Xu Yang, Shuang Sun, Zeliang Ma, Yunsong Liu, Jun Wang, Hui Zhu, Zhouguang Hui
Format: Article
Language:English
Published: Wiley 2021-12-01
Series:Thoracic Cancer
Subjects:
chemoradiotherapy
endostar
meta‐analysis
NSCLC
Online Access:https://doi.org/10.1111/1759-7714.14188

Internet

https://doi.org/10.1111/1759-7714.14188

Similar Items